Carbamazepine and apixaban — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Carbamazepine may reduce apixaban exposure and increase thrombosis risk.
Carbamazepine is a strong enzyme inducer and can reduce exposure to some direct oral anticoagulants, risking treatment failure. In a patient being treated for DVT, reduced anticoagulant effect is clinically important. The prescriber should review the anticoagulant choice.
Reference: https://www.pharmacyregulation.org/registration-assessment#stage-8-order-91